STEMI - Nursing Case Study

Pathophysiology

• Primary mechanism: STEMI (ST-Elevation Myocardial Infarction) occurs when a coronary artery is completely blocked, often by a ruptured atherosclerotic plaque, leading to an interruption of blood flow and oxygen to the heart muscle.

• Secondary mechanism: The lack of oxygen (ischemia) causes myocardial cells to switch to anaerobic metabolism, leading to the accumulation of lactic acid and eventual cell death (infarction) if reperfusion is not promptly restored.

• Key complication: Extended ischemia results in irreversible damage to cardiac muscle tissue, leading to decreased cardiac output and potential heart failure, emphasizing the need for rapid intervention.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Hypertension, hyperlipidemia, smoking history (20 pack-years)

• Current medications: Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe chest pain radiating to the left arm

• Key symptoms: Shortness of breath, diaphoresis, nausea

• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 37.2°C, oxygen saturation 92% on room air

Section 1

As the healthcare team begins the initial assessment, further examination reveals critical details about the patient's condition. On auscultation, the presence of crackles in both lung bases suggests pulmonary congestion, indicative of potential heart failure due to decreased cardiac output from the myocardial infarction. The patient's jugular venous pressure is elevated, reinforcing concerns about developing heart failure. An electrocardiogram confirms significant ST elevations in the anterior leads, consistent with an anterior wall STEMI. In addition, laboratory tests show elevated cardiac biomarkers, with troponin I levels significantly above the normal range, indicating acute myocardial injury.

Despite receiving oxygen therapy, the patient's oxygen saturation remains at 92%, suggesting impaired gas exchange possibly due to pulmonary edema. The clinical team decides to initiate intravenous nitroglycerin to reduce the workload on the heart by decreasing preload and afterload, coupled with furosemide to manage fluid overload. Continuous monitoring is crucial to evaluate the patient's response to these interventions, as well as to assess for any potential complications such as arrhythmias or further hemodynamic instability.

However, within the next few hours, the patient's condition changes. He experiences increasing respiratory distress and becomes tachypneic, with a respiratory rate climbing to 30 breaths per minute. His blood pressure drops to 95/60 mmHg, raising concerns about cardiogenic shock. This change necessitates a swift reevaluation of the treatment strategy, prompting considerations for more aggressive interventions such as mechanical support or revascularization procedures. The healthcare team must prioritize stabilizing the patient's hemodynamic status while preparing for potential complications arising from ongoing ischemia and compromised cardiac function.

Section 2

As the patient's condition deteriorates, the healthcare team swiftly shifts focus to the new diagnostic results that provide crucial insights into the underlying issues. A repeat echocardiogram reveals a marked reduction in left ventricular ejection fraction, now at 30%, further confirming significant systolic dysfunction. This finding correlates with the patient's clinical signs of heart failure and the recent drop in blood pressure. Additionally, a chest X-ray shows bilateral infiltrates consistent with worsening pulmonary edema, which aligns with the patient's respiratory distress and low oxygen saturation levels.

Arterial blood gases are obtained to better understand the patient's respiratory status. The results show a pH of 7.32, pCO2 of 48 mmHg, and pO2 of 60 mmHg, indicating a respiratory acidosis with hypoxemia. These findings are suggestive of inadequate ventilation and impaired gas exchange, likely exacerbated by the ongoing myocardial ischemia and fluid overload. The team recognizes the need for immediate intervention to address the compromised respiratory and cardiovascular status.

Given these developments, the healthcare team considers initiating non-invasive positive pressure ventilation (NIPPV) to improve oxygenation and reduce the work of breathing. Concurrently, they evaluate the potential benefits of advanced mechanical support, such as an intra-aortic balloon pump, to bolster cardiac output and stabilize hemodynamics. The team also prepares for possible percutaneous coronary intervention to restore coronary perfusion. These steps are critical in managing the patient's complex condition and preventing further complications, as the team works diligently to stabilize him and optimize cardiac function.

Section 3

As the healthcare team begins non-invasive positive pressure ventilation (NIPPV), they closely monitor the patient's response to the intervention. Initial assessment shows a slight improvement in oxygen saturation, now at 88%, and a reduction in respiratory rate from 32 to 26 breaths per minute. Despite these changes, the patient remains in significant distress, with continued use of accessory muscles and persistent cyanosis around the lips and fingertips. The heart rate has increased to 120 beats per minute, and blood pressure remains low at 85/50 mmHg, indicating ongoing hemodynamic instability.

The team decides to initiate an intra-aortic balloon pump (IABP) to support cardiac output. As the IABP begins functioning, there is a noticeable improvement in the patient's hemodynamics. Blood pressure stabilizes slightly at 95/60 mmHg, and heart rate decreases to 110 beats per minute. However, the patient remains lethargic and minimally responsive, raising concerns about cerebral perfusion. A repeat arterial blood gas analysis reveals a pH of 7.34, pCO2 of 45 mmHg, and pO2 of 65 mmHg, indicating partial correction of the acidosis and slight improvement in oxygenation, but still insufficient.

While the patient shows some response to the interventions, the team remains vigilant for new complications. They note a decrease in urine output to 15 mL/hour, suggesting potential acute kidney injury due to poor perfusion. The laboratory results confirm elevated creatinine levels at 2.2 mg/dL and a blood urea nitrogen level of 35 mg/dL. These findings prompt the team to consider adjusting current diuretic therapy and optimizing fluid management to prevent further renal compromise. As discussions continue regarding urgent percutaneous coronary intervention, the team's focus is on stabilizing the patient's cardiac and renal function while preparing for further definitive treatment.

Section 4

As the healthcare team continues to monitor the patient's progress, a new complication emerges. The patient begins to develop increasing pulmonary congestion, evidenced by escalating crackles on auscultation and rising jugular venous pressure, suggesting worsening heart failure. Despite the use of the intra-aortic balloon pump (IABP) and NIPPV, the patient remains in significant respiratory distress, with persistent cyanosis and minimal improvement in oxygen saturation, now fluctuating between 86% and 88%. The respiratory rate remains elevated at 28 breaths per minute, indicating sustained respiratory compromise.

Given the patient's deteriorating pulmonary status and the ongoing signs of fluid overload, the team decides to modify the patient's diuretic therapy. They cautiously increase the dose of intravenous furosemide to promote diuresis and relieve pulmonary congestion, while closely monitoring electrolyte levels and renal function to prevent further complications. Concurrently, they initiate discussions on the urgent necessity for percutaneous coronary intervention (PCI) to address the underlying myocardial ischemia contributing to the patient's hemodynamic instability.

In the meantime, the team remains attentive to the patient's neurological status. Despite slight hemodynamic improvements, the patient continues to exhibit altered mental status with minimal responsiveness, raising concerns about adequate cerebral perfusion. The healthcare team performs a rapid bedside assessment, noting sluggish pupillary response and delayed capillary refill, which further underscores the critical need to stabilize the patient's condition. The team prioritizes efforts to optimize both cardiac output and oxygen delivery, while coordinating with the interventional cardiology team to expedite the PCI as a definitive step in resolving the patient's ischemic crisis.

Section 5

As the healthcare team intensifies their efforts to stabilize the patient, they observe a change in the patient's status that demands urgent attention. The patient's blood pressure begins to trend downward, now reading at 88/56 mmHg, and heart rate remains elevated at 118 beats per minute, indicating a potential progression towards cardiogenic shock. Despite the increased dose of intravenous furosemide, urine output is minimal at 15 mL/hour, raising concerns about renal perfusion and impending acute kidney injury.

In response, the team re-evaluates the hemodynamic support strategy, considering the potential need for vasopressor therapy to maintain adequate perfusion pressure. They decide to initiate a low-dose norepinephrine infusion while closely monitoring mean arterial pressure and end-organ perfusion indicators. Additionally, blood gas analysis reveals a worsening metabolic acidosis with an arterial pH of 7.28 and a bicarbonate level of 18 mEq/L, further complicating the clinical picture and necessitating careful adjustment of supportive measures to address the acid-base imbalance.

This deterioration prompts a reassessment of the patient's overall treatment plan, with a renewed emphasis on expediting the percutaneous coronary intervention (PCI). The interventional cardiology team is urgently mobilized to proceed with the procedure, recognizing the critical importance of revascularizing the ischemic myocardium to halt the downward spiral of hemodynamic instability. In preparation for PCI, the team ensures that all supportive measures are optimized to maintain the patient's stability during transport to the catheterization lab, while continuing to address the multifaceted challenges of managing heart failure, impaired perfusion, and acid-base derangements.